For the first time in the history of the State Expert Center of the Ministry of Health of Ukraine, an agreement has been signed with the U.S. Food and Drug Administration (FDA).
The landmark event took place during the working visit of the Center’s Director Mykhailo Babenko, as part of the delegation of the Ministry of Health of Ukraine, to the FDA.
The Authorization and Confidentiality Commitment Agreement between the Center and the FDA was signed by Mykhailo Babenko and FDA Deputy Commissioner for Global Policy and Strategy Mark Abdoo.
“This is the first agreement of its kind in the history of the Center and, I hope, the first step toward future long-term mutually beneficial cooperation,” Mykhailo Babenko emphasized during the signing. He thanked the FDA for its readiness to begin a new stage in the relations between the national regulators of the two countries.
According to Mykhailo Babenko, in recent years the State Enterprise “State Expert Center of the Ministry of Health of Ukraine” has been actively developing cooperation with international organizations and national regulatory authorities in the field of medicinal product circulation in various areas. It is thanks to this that, despite the challenges of war, a reliable foundation has been created for the further growth and development of the Center and of Ukraine’s pharmaceutical industry as a whole.
Cooperation with the FDA will be another important stage of integration with international practice in the field of medicinal product regulation.
“I am confident that the signing of the Agreement will mark the beginning of a two-way dialogue, an exchange of ideas and initiatives for a common goal – to increase the availability and quality of medical care for every citizen of our country and of the world as a whole,” said Mykhailo Babenko.
The delegation expresses its gratitude to the SAFEMed/USAID project for comprehensive support and assistance in organizing the visit to the FDA.
